Strong first-day trading for iX Biopharma
Shares close trading up 21.7 per cent at S$0.56 after intra-day high of S$0.64
Singapore
SPECIALTY pharmaceutical company iX Biopharma made a strong trading debut on the Singapore Exchange Catalist board on Wednesday.
Shares of iX Biopharma, the second healthcare company in less than two months to breathe life into an otherwise moribund initial public offering (IPO) market, kicked off trading at S$0.495, 3.5 Singapore cents or 7.6 per cent above its IPO price of S$0.46.
After an intra-day low of S$0.49, the stock galloped to an intra-day high of S$0.64 before closing at S$0.56, up up 10 cents or 21.7 per cent fr…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Hong Kong regulator to probe PwC auditing role over Evergrande
US: S&P, Dow open flat as Middle East jitters ease, Netflix weighs on Nasdaq
DBS puts 46 HDB shops, private strata retail units on market for S$210 million
China to facilitate Hong Kong IPOs and expand Stock Connect
Global equity funds see surge in outflows as rate cut hopes fade
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece